Clinical Trials

2 enrolled

Leukemia, Biphenotypic, Acute, Neoplasm, Residual

NCT02988466 2025-05-28

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

78 enrolled 16 charts

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Neoplasm, Residual, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT06936345 2025-04-20

Effective Treatments for Dizziness After BPPV: A Clinical Study

56 enrolled

Vestibular Diseases, Neoplasm, Residual

NCT03367299 2025-01-22

LAL2317

149 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04716075 2025-01-16

ACALLO

29 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual, Lymphoma, Mantle-Cell

NCT03524235 2024-11-12

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

LymphoidOther hematologic neoplasmPlasma cell

20 enrolled

Hodgkin Disease, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT05117879 2024-10-17

R0 Resection Rate Between CSP, cEMR and hEMR for 1-2 cm Colorectal SSLs

120 enrolled

Neoplasm, Residual

NCT06404593 2024-05-08

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

270 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

24 enrolled

CNS

Neuroblastoma, Neoplasm, Residual

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

6 enrolled 10 charts

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05093192 2023-09-08

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

26 enrolled

Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT06000306 2023-08-22

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

192 enrolled

Recurrence, Neoplasm, Residual

NCT03512197 2023-08-21

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Phase 3 Completed

511 enrolled 26 charts

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04712942 2023-08-21

Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

14 enrolled

Myeloid

Myelodysplastic Syndromes, Neoplasm, Residual

NCT02185781 2023-03-30

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

6 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03109093 2023-03-21

Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia

83 enrolled

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199030 2023-03-20

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

8 enrolled

Lymphoma, Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05637580 2022-12-05

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Phase EARLY_PHASE1 Completed

110 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT04130152 2022-10-25

PROMETEO II

22 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual

NCT02627261 2022-09-06

MMRD

48 enrolled

Plasma cell

Multiple Myeloma, Neoplasm, Residual

NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Phase 4 Completed

1,883 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

26 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03627208 2022-06-01

Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch

150 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02067143 2021-09-08

LAL1913

204 enrolled

Neoplasm Metastasis, Neoplasm, Residual

NCT02900625 2021-01-27

VMRDO

240 enrolled

Neoplasm, Residual

NCT03093207 2020-11-17

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Phase 2/3 Completed

34 enrolled 8 charts

Aggressive Periodontitis, Neoplasm, Residual

NCT03788850 2020-08-27

FARDCC

397 enrolled

Gynecologic

Uterine Cervical Dysplasia, Neoplasm, Residual

NCT01460498 2020-03-05

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

MyeloidOther hematologic neoplasm

3 enrolled

Leukemia, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT02870777 2020-03-04

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

Phase 2/3 Completed

743 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT02673008 2020-02-25

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Phase 2/3 Completed

206 enrolled

Recurrence, Neoplasm, Residual

NCT01207388 2020-02-10

BLAST

116 enrolled 23 charts 1 FDA

Burkitt Lymphoma, Leukemia, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00339898 2019-12-17

Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma

414 enrolled

Sarcoma

Sarcoma, Ewing, Neoplasm, Residual

NCT02527447 2019-10-30

Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)

15 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT01594892 2019-09-04

DOSIS

60 enrolled

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplastic Processes, Pain, Neoplasm, Residual

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Phase 4 Completed

60 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

NCT01401959 2018-06-15

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

127 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm, Residual

NCT03491033 2018-04-10

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

250 enrolled

Neoplasm, Residual

NCT01347996 2017-11-29

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

Phase 4 Completed

84 enrolled

Leukemia, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT02339805 2017-07-07

LymphoSeq